Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SciVision Biotech Inc | 787.96m | 196.83m | 7.27bn | 64.00 | 39.82 | 4.70 | 27.96 | 9.23 | 2.67 | 2.67 | 10.33 | 22.67 | 0.3601 | 2.14 | 8.34 | -- | 9.00 | 6.67 | 10.09 | 7.41 | 74.13 | 69.94 | 24.98 | 25.00 | 2.90 | -- | 0.1739 | 79.74 | 27.93 | 16.69 | 25.53 | 15.41 | -31.16 | 11.38 |
CHC Healthcare Group | 3.73bn | 341.88m | 7.79bn | 160.00 | 25.17 | 1.26 | 8.44 | 2.09 | 1.86 | 1.86 | 19.97 | 36.92 | 0.2753 | 4.08 | 3.97 | -- | 2.52 | 3.23 | 3.00 | 3.80 | 26.37 | 30.12 | 9.15 | 13.16 | 2.01 | 10.78 | 0.455 | 81.75 | 30.35 | 9.11 | 17.47 | 5.31 | 9.69 | 2.25 |
Excelsior Medical Co Ltd | 8.27bn | 729.96m | 13.82bn | 774.00 | 19.00 | 1.66 | 11.90 | 1.67 | 4.67 | 4.67 | 52.96 | 53.65 | 0.4706 | 5.36 | 5.48 | -- | 5.14 | 4.94 | 10.49 | 9.25 | 20.25 | 20.22 | 10.91 | 10.60 | 1.28 | -- | 0.0914 | 83.22 | 14.56 | 5.35 | 11.86 | 10.58 | 31.53 | 7.24 |
Vizionfocus Inc | 2.83bn | 654.83m | 13.92bn | -- | 19.93 | 4.35 | 13.25 | 4.92 | 12.14 | 12.14 | 52.60 | 55.63 | 0.6401 | 6.99 | 6.07 | -- | 17.03 | 12.00 | 22.00 | 16.54 | 40.90 | 37.01 | 26.60 | 20.52 | 2.90 | -- | 0.2795 | 28.73 | 40.23 | 52.18 | 79.65 | 233.89 | 71.42 | -- |
Taidoc Technology Corp | 4.35bn | 1.02bn | 15.50bn | 829.00 | 15.19 | 1.67 | 12.09 | 3.57 | 10.70 | 10.70 | 45.43 | 97.11 | 0.3468 | 1.95 | 3.98 | -- | 8.51 | 17.60 | 11.73 | 22.98 | 40.63 | 50.73 | 24.55 | 28.49 | 3.14 | -- | 0.0659 | 68.99 | -50.07 | 2.03 | -69.93 | 3.02 | -34.71 | 4.58 |
Visco Vision Inc | 2.69bn | 432.93m | 16.10bn | -- | 37.24 | 5.38 | 19.33 | 5.99 | 6.86 | 6.86 | 42.60 | 47.46 | 0.5397 | 2.85 | 5.99 | -- | 8.56 | 11.68 | 11.17 | 15.80 | 39.40 | 40.56 | 15.86 | 17.72 | 1.16 | 21.32 | 0.2707 | 43.00 | -13.68 | 25.82 | -51.15 | 8.74 | 0.8293 | -- |
Data as of Jul 30 2024. Currency figures normalised to Vizionfocus Inc's reporting currency: Taiwan Dollar TWD
0.04%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
SSgA Funds Management, Inc.as of 03 Jul 2024 | 22.07k | 0.04% |
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.